ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2541

High Risk of Intensive Care Unit Admission in Rheumatoid Arthritis Patients: A Population Based Study

Christine Peschken1, Carol A. Hitchon2, Allan Garland3, Charles N. Bernstein3, Randy Fransoo4 and Ruth Ann Marrie3, 1Medicine & Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, 2University of Manitoba, Winnipeg, MB, Canada, 3Internal Medicine, University of Manitoba, Winnipeg, MB, Canada, 4Manitoba Centre for Health Policy, University of Manitoba, Winnipeg, MB, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Comorbidity and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects V: Comorbidities in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Comorbidity in Rheumatoid arthritis (RA) has been a focus of intensive research in recent years, but little is known about the incidence of critical illness in RA, as defined by admissions to Intensive Care Units (ICU).   While hospital care is the largest component of health resource use in Canada, admissions to ICU consume a disproportionate share of costs. Using a large, population-based dataset we determined the incidence of ICU admissions in RA patients.

Methods:

 In a stable population of over 900,000 adults, we used hospital claims from a large administrative database linked to a population based ICU database to determine the incidence of ICU admissions from 2000-2010.  RA patients were compared to a cohort from the general population, matched on sex, year of birth and region of residence, with up to 5 controls for each case. Individuals with any diagnostic codes (ICD-9/10) for autoimmune inflammatory disease were excluded from the general population cohort. We estimated the annual incidence rates by age group, sex, and geographic region by stratification; (number of persons in each cohort who had at least one ICU admission/ number of persons alive in that cohort at year-end). The results were age and sex standardized to the general Canadian population. The incidence of ICU admission between the RA cohorts and matched cohorts were compared using incidence rate ratios (RR). We compared the 10 year cumulative incidence of ICU admission for the period 2000-2010: (number of persons with disease who had at least one episode of critical illness/ person-years at risk). 

Results:

 The age and sex standardized annual incidence of ICU admission was relatively stable over the 10 year period, at 0.82-1.18% for RA patients compared to 0.32-0.59% for the matched cohort, RR 1.53-3.14. The risk of ICU admission increased with age (age 18-39, 0.38% for RA vs. 0.10% for controls; age 40-59, 0.81% vs. 0.31%; age 60+ 1.74% vs. 1.09%) in a similar pattern to that seen in the general population. The 10 year cumulative incidence rate for RA patients was7.68% compared to 4.73% in the general population, with a RR of 1.62 (95% CI 1.46-1.80). 

Conclusion:   The risk of ICU admission is significantly increased in RA patients compared to the general population, with more than 1% of adults with RA developing critical illness each year, and a 10 year risk near 8%.  This represents a substantial disease burden and cost to the healthcare system.  Further work is ongoing to determine causes and predictors of ICU admission.


Disclosure:

C. Peschken,
None;

C. A. Hitchon,
None;

A. Garland,
None;

C. N. Bernstein,
None;

R. Fransoo,
None;

R. A. Marrie,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-risk-of-intensive-care-unit-admission-in-rheumatoid-arthritis-patients-a-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology